GSK
Price
$48.13
Change
+$0.01 (+0.02%)
Updated
Sep 11 closing price
Capitalization
95.83B
45 days until earnings call
Intraday BUY SELL Signals
IXJ
Price
$100.76
Change
-$0.13 (-0.13%)
Updated
Sep 11 closing price
Net Assets
4.14B
Intraday BUY SELL Signals
Interact to see
Advertisement

GSK vs IXJ

GSK vs IXJ Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GSK vs. IXJ commentary
Sep 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSK is a Hold and IXJ is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GSKIXJ
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 27 days ago
63%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
54%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bearish Trend 3 days ago
43%
Bullish Trend 3 days ago
77%
COMPARISON
Comparison
Sep 14, 2026
Stock price -- (GSK: $48.13)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSK’s FA Score shows that 1 FA rating(s) are green while .

  • GSK’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GSK’s TA Score shows that 3 TA indicator(s) are bullish.

  • GSK’s TA Score: 3 bullish, 7 bearish.

Price Growth

GSK (@Pharmaceuticals: Major) experienced а -3.53% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.36%. For the same industry, the average monthly price growth was -3.99%, and the average quarterly price growth was +5.78%.

Reported Earning Dates

GSK is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-4.36% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
GSK
Daily Signal:
Gain/Loss:
IXJ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ZOCT28.020.04
+0.13%
Innovator Eq Dfnd Prt ETF - 1 Yr Oct
BDCZ15.110.01
+0.07%
UBS ETRACS Wells Fargo® Busn Dev Co ETN
PQOC31.32N/A
N/A
PGIM NASDAQ-100 BUFFER 12 ETF - OCTOBER
JSCP46.37-0.06
-0.13%
JPMorgan Short Duration Core Plus ETF
ZTR6.60-0.01
-0.15%
Virtus Total Return Fund

IXJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, IXJ has been closely correlated with LLY. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IXJ jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXJ
1D Price
Change %
IXJ100%
-0.13%
LLY - IXJ
71%
Closely correlated
-0.65%
MRK - IXJ
69%
Closely correlated
-0.54%
GSK - IXJ
66%
Closely correlated
+0.02%
PFE - IXJ
63%
Loosely correlated
+0.25%
ABBV - IXJ
62%
Loosely correlated
+0.83%
More